AAAAAA

   
Results: 1-16 |
Results: 16
Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial
Authors: Factor, SA Friedman, JH Lannon, MC Oakes, D Bourgeois, K
Citation: Sa. Factor et al., Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial, MOVEMENT D, 16(1), 2001, pp. 135-139
[I-123]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression
Authors: Marek, K Innis, R van Dyck, C Fussell, B Early, M Eberly, S Oakes, D Seibyl, J
Citation: K. Marek et al., [I-123]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression, NEUROLOGY, 57(11), 2001, pp. 2089-2094
A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPELT in parkinsonism
Authors: Marek, K Seibyl, J Holloway, R Kieburtz, K Oakes, D Lang, A Yim, J Dey, H Cellar, J Fussell, B Broshjeit, S Early, M Smith, EO Sudarsky, L Johnson, KA Corwin, C Johnson, D Lajoie, S Reich, SG Frost, JJ Goldberg, P Flesher, JE Feigin, A Mazurkiewicz, J Castronuovo, J Joseph, F Cove, G DiRocco, A Olanow, CW Machac, J Cotei, D Webner, P Rudolph, A Day, D Casaceli, C Freimuth, A Orme, C Hodgeman, K Eberly, S Henry, E Morgan, G Westwater, D Haley, JB Henry, E
Citation: K. Marek et al., A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPELT in parkinsonism, NEUROLOGY, 57(10), 2001, pp. S52-S59
Biometrika Centenary: Survival analysis
Authors: Oakes, D
Citation: D. Oakes, Biometrika Centenary: Survival analysis, BIOMETRIKA, 88(1), 2001, pp. 99-142
Survival analysis
Authors: Oakes, D
Citation: D. Oakes, Survival analysis, J AM STAT A, 95(449), 2000, pp. 282-285
The application of predictive models in the environmental risk assessment of ECONOR (c)
Authors: Boxall, ABA Oakes, D Ripley, P Watts, CD
Citation: Aba. Boxall et al., The application of predictive models in the environmental risk assessment of ECONOR (c), CHEMOSPHERE, 40(7), 2000, pp. 775-781
A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism
Authors: Marek, K Seibyl, J Holloway, R Kieburtz, K Oakes, D Lang, A Yim, J Dey, H Cellar, J Fussell, B Broshjeit, S Early, M Smith, EO Sudarsky, L Johnson, KA Corwin, C Johnson, D Lajoie, S Reich, SG Frost, JJ Goldberg, P Flesher, JE Feigin, A Mazurkiewicz, J Castronuovo, J Joseph, F DiRocco, A Olanow, CW Machac, J Cotei, D Webner, P Rudolph, A Day, D Casaceli, C Freimuth, A Orme, C Hodgeman, K Eberly, S Henry, E Morgan, G Haley, JB Henry, E
Citation: K. Marek et al., A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism, NEUROLOGY, 55(10), 2000, pp. 1540-1547
Hemostatic function and coronary artery disease - Response
Authors: Moss, AJ Goldstein, RE Marder, VJ Sparks, CE Oakes, D Greenberg, H Weiss, JJ Zareba, W Brown, MW Liang, CS Lichstein, E Little, WC Gillespie, JA Van Voorhees, L Krone, RJ Bodenheimer, MM Hochman, J Dwyer, EM Arora, R Marcus, FI Watelet, LFM Case, RB
Citation: Aj. Moss et al., Hemostatic function and coronary artery disease - Response, CIRCULATION, 101(18), 2000, pp. E195-E195
Regression in a bivariate copula model
Authors: Oakes, D Ritz, J
Citation: D. Oakes et J. Ritz, Regression in a bivariate copula model, BIOMETRIKA, 87(2), 2000, pp. 345-352
Detection of a group of risk factors in coronary disease using a new carriership analysis approach
Authors: Watelet, LFM Moss, AJ Zareba, W Oakes, D Ryan, D
Citation: Lfm. Watelet et al., Detection of a group of risk factors in coronary disease using a new carriership analysis approach, AM J CARD, 86(11), 2000, pp. 1253
Direct calculation of the information matrix via the EM algorithm
Authors: Oakes, D
Citation: D. Oakes, Direct calculation of the information matrix via the EM algorithm, J ROY STA B, 61, 1999, pp. 479-482
Mortality in DATATOP - Reply
Authors: Shoulson, I Oakes, D Olanow, CW
Citation: I. Shoulson et al., Mortality in DATATOP - Reply, ANN NEUROL, 45(1), 1999, pp. 139-139
The placebo response in Parkinson's disease
Authors: Shetty, N Friedman, JH Kieburtz, K Marshall, FJ Oakes, D
Citation: N. Shetty et al., The placebo response in Parkinson's disease, CLIN NEUROP, 22(4), 1999, pp. 207-212
Association between nurse-physician collaboration and patient outcomes in three intensive care units
Authors: Baggs, JG Schmitt, MH Mushlin, AI Mitchell, PH Eldredge, DH Oakes, D Hutson, AD
Citation: Jg. Baggs et al., Association between nurse-physician collaboration and patient outcomes in three intensive care units, CRIT CARE M, 27(9), 1999, pp. 1991-1998
Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease
Authors: Friedman, J Lannon, M Comella, C Factor, S Kurlan, R Richard, I Parsa, M Pfeiffer, R Davies, R Janko, K Brown, D Gardner, I Pearson, N Large, K Rast, S Oakes, D Goetz, C Paulson, G Marshall, F Kieburtz, K Rudolph, A Bourgeois, K Casacelli, C Freimuth, A Guthrie, B Pelusio, R Watts, A Tariot, P Raubertas, R Greenamyre, T
Citation: J. Friedman et al., Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease, N ENG J MED, 340(10), 1999, pp. 757-763
Thrombogenic factors and recurrent coronary events
Authors: Moss, AJ Goldstein, RE Marder, VJ Sparks, CE Oakes, D Greenberg, H Weiss, HJ Zareba, W Brown, MW Liang, CS Lichstein, E Little, WC Gillespie, JA Van Voorhees, L Krone, RJ Bodenheimer, MM Hochman, J Dwyer, EM Arora, R Marcus, FI Watelet, LFM Case, RB
Citation: Aj. Moss et al., Thrombogenic factors and recurrent coronary events, CIRCULATION, 99(19), 1999, pp. 2517-2522
Risultati: 1-16 |